adult add
ADDA Headline Archive

September 2005 Headlines

News Release: Health Canada Adopts Recommendation of Expert Panel and Reinstates ADDERALL XR® (CII) in Canada (PDF)

July 2005 Headlines

Questions & Answers about ADDERALL® and
ADDERALL XR®

March 2005 Headlines

Lilly Announces Important Liver Safety Update
to Strattera Label
Eli Lilly and Company announced that it has added a bolded warning to the product label for Strattera, an attention deficit/hyperactivity disorder (ADHD) medication. The bolded warning indicates that the medication should be discontinued in patients with jaundice (yellowing of the skin or whites of the eyes) or laboratory evidence of liver injury. Read More adult add

Senate Resolution Declares September 7th
AD/HD Awareness Day
ADDA announces success in its effort to spearhead passage of a U.S. Senate resolution designating a “National Attention Deficit Disorder Awareness Day” on September 7, 2004 – a major step toward accomplishing ADDA’s goal of spreading vital information and encouragement. Read More